Neurocrine Biosciences
NBIX
#1636
Rank
NZ$22.94 B
Marketcap
NZ$230.12
Share price
-0.72%
Change (1 day)
-10.25%
Change (1 year)
Neurocrine Biosciences is an American biopharmaceutical company that develops treatments for neurological and endocrine-related diseases and disorders.

Market capitalization of Neurocrine Biosciences (NBIX)

Market cap: NZ$22.94 Billion

As of January 2026 Neurocrine Biosciences has a market cap of NZ$22.94 Billion. This makes Neurocrine Biosciences the world's 1636th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Neurocrine Biosciences from 1996 to 2026

End of year Market Cap

Year Marketcap Change
2026NZ$22.94 B-8.25%
2025NZ$25.00 B-0.1%
2024NZ$25.03 B22.29%
2023NZ$20.47 B13.19%
2022NZ$18.08 B52.89%
2021NZ$11.82 B-4.69%
2020NZ$12.41 B-15.72%
2019NZ$14.72 B52.36%
2018NZ$9.66 B-0.02%
2017NZ$9.66 B99.2%
2016NZ$4.85 B-31.93%
2015NZ$7.12 B227.03%
2014NZ$2.18 B184.81%
2013NZ$0.76 B26.7%
2012NZ$0.60 B0.4%
2011NZ$0.60 B10.73%
2010NZ$0.54 B229.9%
2009NZ$0.16 B-22.6%
2008NZ$0.21 B-6.18%
2007NZ$0.22 B-59.54%
2006NZ$0.56 B-83.55%
2005NZ$3.40 B35.02%
2004NZ$2.52 B-14.8%
2003NZ$2.96 B10.75%
2002NZ$2.67 B-28.66%
2001NZ$3.74 B98.17%
2000NZ$1.89 B84.91%
1999NZ$1.02 B314.37%
1998NZ$0.24 B2.89%
1997NZ$0.24 B-7.69%
1996NZ$0.26 B

End of Day market cap according to different sources

On Jan 17th, 2026 the market cap of Neurocrine Biosciences was reported to be:

NZ$22.94 Billion
by Nasdaq info icon info icon
NZ$22.94 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Repligen
RGEN
NZ$15.85 B-30.91%๐Ÿ‡บ๐Ÿ‡ธ USA
Royalty Pharma
RPRX
NZ$40.09 B 74.73%๐Ÿ‡ฌ๐Ÿ‡ง UK
Palatin Technologies
PTN
NZ$51.94 M-99.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
NZ$1.618 T 6,952.11%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
NZ$658.49 B 2,769.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
NZ$253.49 B 1,004.83%๐Ÿ‡บ๐Ÿ‡ธ USA
ANI Pharmaceuticals
ANIP
NZ$3.31 B-85.57%๐Ÿ‡บ๐Ÿ‡ธ USA
Athersys
ATHX
NZ$1.44 M-99.99%๐Ÿ‡บ๐Ÿ‡ธ USA